Any of this week’s high-flyers could experience the effects of gravity in short order. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) reported disappointing Acthar sales in the first quarter. If it does so again in the second quarter, the stock will take some licks. After a run of more than 50% this year, Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) could be due for a breather. However, I suspect both of these stocks will do well over the long run.
Amedisys, though, operates in a tough industry. The company experienced declining revenue and a huge earnings drop in its most recent quarter. If Amedisys doesn’t report significantly improved results next quarter, expect the current upward trajectory to reverse again.
The article 3 Humongous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.
Fool contributor Keith Speights and The Motley Fool have no position in any of the stocks mentioned.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.